Skip to main content

Bioverativ Inc (NASDAQ:BIVV) Investor Lawsuit Filed Against Acquisition By Sanofi

  • If you purchased shares of Bioverativ Inc (NASDAQ:BIVV), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

March 5, 2018 - The case was dismissed. February 15, 2018 - An investor, who currently holds shares of Bioverativ Inc (NASDAQ:BIVV), filed a lawsuit in effort to halt the proposed takeover of Bioverativ Inc. by Sanofi. Waltham, MA based Bioverativ Inc. (Bioverativ) is a biotechnology company. The Company is focused on the discovery, research, development and commercialization of thera...



You must register (for free) or login to view the entire case.